URGN · All filings · Read this filing
What changed 10-Q
Item 1. Legal Proceedings
2025-11-06 compared with 2025-08-07 · 1 added, 0 removed, 16 unchanged (6% of the section changed)
11 unchanged sentences
By order dated February 27, 2025, the court approved the parties’ joint stipulation to remove the Markman hearing and any related claim-construction proceedings from the court’s calendar.
+Added: Additionally, by the court’s order dated August 28, 2025, the parties stipulated that upon final approval of Teva’s ANDA, the commercial manufacture, use, sale, or offer for sale within the United States, or importation into the United States, of that product would infringe certain claims of the patents asserted in the action, thus narrowing the scope of the action to the validity of those certain patent claims.
This matter is scheduled for a bench trial in October 2026.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.